Lydia Eccersley
Impact in
-
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
-
- Multiple Myeloma Research and Treatments 8
-
- Cancer therapeutics and mechanisms 3
- Protein Degradation and Inhibitors 2
- Histone Deacetylase Inhibitors Research 1
- Co-authors
- Christopher Wård (7 shared papers)Sumita Roy–Ghanta (7 shared papers)Astrid McKeown (7 shared papers)María‐Victoria Mateos (6 shared papers)Malcolm H.A. Rustin (1 shared paper)A. Victor Hoffbrand (1 shared paper)P. Joy Ho (6 shared papers)Kihyun Kım (5 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)British Journal of Haematology (1 paper)American Journal of Hematology (1 paper)Blood (1 paper)Clinical Lymphoma Myeloma & Leukemia (2 papers)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Lydia Eccersley
9 papers receiving 28 citations
Peers
Comparison fields: 5 of 12
- Hematology 20
- Oncology 13
- Genetics 5
- Pathology and Forensic Medicine 5
- Molecular Biology 17
Countries citing papers authored by Lydia Eccersley
This map shows the geographic impact of Lydia Eccersley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lydia Eccersley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lydia Eccersley more than expected).
Fields of papers citing papers by Lydia Eccersley
This network shows the impact of papers produced by Lydia Eccersley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lydia Eccersley. The network helps show where Lydia Eccersley may publish in the future.
Co-authors
The 25 scholars most cited alongside Lydia Eccersley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 12 | |
| 2 | 2009 | 5 | |
| 3 | 2021 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2025 | 1 |
About Lydia Eccersley
Lydia Eccersley is a scholar working on Hematology, Molecular Biology, Infectious Diseases, Genetics and Pharmacology, having authored 9 papers that have together received 28 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (8 papers), Cancer therapeutics and mechanisms (3 papers), HIV/AIDS drug development and treatment (3 papers), Protein Degradation and Inhibitors (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Cancer Treatment and Pharmacology (1 paper), Cholinesterase and Neurodegenerative Diseases (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Hematology (20 citations), Oncology (13 citations), Genetics (5 citations), Pathology and Forensic Medicine (5 citations) and Molecular Biology (17 citations). Lydia Eccersley has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Christopher Wård, Sumita Roy–Ghanta, Astrid McKeown, María‐Victoria Mateos, Malcolm H.A. Rustin, A. Victor Hoffbrand, P. Joy Ho, Kihyun Kım, Marek Hus and Joanna Opalinska. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Haematology, American Journal of Hematology, Blood and Clinical Lymphoma Myeloma & Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.